blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3413878

EP3413878 - ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.02.2022
Database last updated on 18.10.2024
FormerThe patent has been granted
Status updated on  12.03.2021
FormerGrant of patent is intended
Status updated on  02.11.2020
FormerExamination is in progress
Status updated on  14.01.2020
FormerRequest for examination was made
Status updated on  16.11.2018
FormerThe international publication has been made
Status updated on  18.08.2017
Formerunknown
Status updated on  28.02.2017
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 30.10.2024 [2024/44]
Applicant(s)For all designated states
Albireo AB
Arvid Wallgrens Backe 20
413 46 Göteborg / SE
[2018/51]
Inventor(s)01 / GILLBERG, Per-Göran
Vissboda 232
694 96 Åsbro / SE
02 / GUSTAFSSON, Nils Ove
Hippodromvägen 7
246 50 Löddeköpinge / SE
03 / LINDBERG, Nils-Olof
Sveagatan 100
216 15 Limhamn / SE
04 / ELVERSSON, Jessica
Veberödsvägen 5
247 50 Dalby / SE
 [2021/14]
Former [2018/51]01 / GILLBERG, Per-Göran
Södermalmsgatan 22
431 69 Mölndal / SE
02 / GUSTAFSSON, Nils Ove
Hippodromvägen 7
246 50 Löddeköpinge / SE
03 / LINDBERG, Nils-Olof
Sveagatan 100
216 15 Limhamn / SE
04 / ELVERSSON, Jessica
Veberödsvägen 5
247 50 Dalby / SE
Representative(s)Novitas Patent AB
P.O. Box 55557
102 04 Stockholm / SE
[2018/51]
Application number, filing date17705975.509.02.2017
[2018/51]
WO2017SE50128
Priority number, dateSE2016005015709.02.2016         Original published format: SE 1650157
[2018/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017138878
Date:17.08.2017
Language:EN
[2017/33]
Type: A1 Application with search report 
No.:EP3413878
Date:19.12.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 17.08.2017 takes the place of the publication of the European patent application.
[2018/51]
Type: B1 Patent specification 
No.:EP3413878
Date:14.04.2021
Language:EN
[2021/15]
Search report(s)International search report - published on:EP17.08.2017
ClassificationIPC:A61K9/50, A61K31/554, A61K31/785, A61K9/16, A61K45/06, A61P1/00, A61P1/16, A61P3/00, A61P43/00, A61P1/12, A61P3/06
[2020/46]
CPC:
A61K9/5073 (EP,RU); A61K31/554 (EP,RU); A61K31/785 (EP,RU);
A61K45/06 (EP); A61K9/16 (RU); A61K9/1617 (RU);
A61K9/1635 (EP,RU); A61K9/1652 (EP); A61K9/5026 (EP);
A61K9/5042 (EP); A61P1/00 (EP); A61P1/12 (EP,RU);
A61P1/16 (EP); A61P3/00 (EP); A61P3/06 (EP,RU);
A61P43/00 (EP) (-)
C-Set:
A61K31/554, A61K2300/00 (EP);
A61K31/785, A61K2300/00 (EP)
Former IPC [2018/51]A61K9/50, A61K31/554, A61K31/785, A61P3/06, A61P1/12
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/51]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ORALE CHOLESTYRAMINFORMULIERUNGEN UND VERWENDUNG DAVON[2018/51]
English:ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF[2018/51]
French:FORMULATION ORALE DE CHOLESTYRAMINE ET UTILISATION ASSOCIÉE[2018/51]
Entry into regional phase14.08.2018National basic fee paid 
14.08.2018Designation fee(s) paid 
14.08.2018Examination fee paid 
Examination procedure14.08.2018Examination requested  [2018/51]
14.08.2018Date on which the examining division has become responsible
28.03.2019Amendment by applicant (claims and/or description)
17.01.2020Despatch of a communication from the examining division (Time limit: M04)
26.03.2020Reply to a communication from the examining division
03.11.2020Communication of intention to grant the patent
25.02.2021Fee for grant paid
25.02.2021Fee for publishing/printing paid
25.02.2021Receipt of the translation of the claim(s)
Opposition(s)17.01.2022No opposition filed within time limit [2022/12]
Fees paidRenewal fee
25.01.2019Renewal fee patent year 03
28.01.2020Renewal fee patent year 04
20.01.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.02.2017
AL14.04.2021
AT14.04.2021
CY14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
MC14.04.2021
MK14.04.2021
MT14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SI14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
[2024/44]
Former [2024/22]HU09.02.2017
AL14.04.2021
AT14.04.2021
CY14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
MC14.04.2021
MK14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SI14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2024/20]HU09.02.2017
AL14.04.2021
AT14.04.2021
CY14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
MC14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SI14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2024/18]HU09.02.2017
AL14.04.2021
AT14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
MC14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SI14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2022/44]AL14.04.2021
AT14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
MC14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SI14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2022/29]AL14.04.2021
AT14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SI14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2022/26]AL14.04.2021
AT14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2022/23]AT14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2022/10]AT14.04.2021
CZ14.04.2021
DK14.04.2021
EE14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
PT16.08.2021
IS22.12.2021
Former [2022/09]AT14.04.2021
CZ14.04.2021
DK14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RO14.04.2021
RS14.04.2021
SE14.04.2021
SK14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2022/08]AT14.04.2021
CZ14.04.2021
DK14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RS14.04.2021
SE14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2022/07]AT14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RS14.04.2021
SE14.04.2021
SM14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2021/52]AT14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
PL14.04.2021
RS14.04.2021
SE14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2021/51]AT14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
RS14.04.2021
SE14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
IS14.08.2021
PT16.08.2021
Former [2021/50]AT14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
SE14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
PT16.08.2021
Former [2021/49]AT14.04.2021
FI14.04.2021
HR14.04.2021
LT14.04.2021
LV14.04.2021
NL14.04.2021
SE14.04.2021
BG14.07.2021
NO14.07.2021
GR15.07.2021
Former [2021/47]AT14.04.2021
FI14.04.2021
LT14.04.2021
NL14.04.2021
BG14.07.2021
Former [2021/46]AT14.04.2021
FI14.04.2021
LT14.04.2021
Cited inInternational search[A]DE3930168  (KNOLL AG [DE]);
 [IDY]US2003124088  (MASUDA KAZUYOSHI [JP], et al);
 [A]JP2006124695  (ZEPHARMA INC, et al);
 [Y]US2015031637  (GILLBERG PER-GÖRAN [SE], et al);
 [A]WO2015193788  (VALPHARMA INTERNAT S P A [IT])
by applicantEP0489423
 EP0549967
 WO9316055
 EP0573848
 WO9418183
 WO9418184
 EP0624593
 EP0624594
 EP0624595
 EP0624596
 WO9605188
 WO9608484
 WO9616051
 WO9733882
 WO9803818
 WO9807449
 EP0864582
 WO9840375
 WO9932478
 WO9935135
 WO9964409
 WO9964410
 DE19825804
 WO0001687
 WO0038725
 WO0038726
 WO0038727
 WO0038728
 WO0038729
 WO0047568
 WO0061568
 WO0166533
 WO0168096
 WO0168637
 EP1173205
 WO0232428
 WO0250051
 EP1273307
 WO03020710
 WO03022286
 WO03022825
 WO03022830
 WO03022804
 WO03061663
 WO03091232
 WO03106482
 WO2004006899
 WO2004076430
 EP1535913
 WO2007009655
 WO2007009656
 WO2008058628
 WO2008058630
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.